c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma

References

• NakamuraTNawaKIchiharaAPartial purification and characterization of hepatocyte growth factor from serum of hepatectomized ratsBiochem Biophys Res Commun19841223145014596477569
   PubMed Web of Science ®Google Scholar
• RussellWEMcGowanJABucherNLPartial characterization of a hepatocyte growth factor from rat plateletsJ Cell Physiol198411921831926715416
   PubMed Web of Science ®Google Scholar
• StokerMGherardiEPerrymanMGrayJScatter factor is a fibroblast-derived modulator of epithelial cell mobilityNature198732761192392422952888
   PubMed Web of Science ®Google Scholar
• ShimaNNagaoMOgakiFTsudaEMurakamiAHigashioKTumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant proteinBiochem Biophys Res Commun103119911802115111581835383
   PubMed Web of Science ®Google Scholar
• SuzukiMShirahaHFujikawaTDes-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinomaJ Biol Chem225200528086409641515582995
   PubMed Web of Science ®Google Scholar
• GherardiEBirchmeierWBirchmeierCVande WoudeGTargeting MET in cancer: rationale and progressNat Rev Cancer12420121228910322270953
   PubMed Web of Science ®Google Scholar
• WangXDeFrancesMCDaiYA mechanism of cell survival: sequestration of Fas by the HGF receptor MetMol Cell220029241142111864613
   PubMed Web of Science ®Google Scholar
• SchmidtCBladtFGoedeckeSScatter factor/hepatocyte growth factor is essential for liver developmentNature223199537365166997027854452
   PubMed Web of Science ®Google Scholar
• UeharaYMinowaOMoriCPlacental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factorNature223199537365167027057854453
   PubMed Web of Science ®Google Scholar
• BorowiakMGarrattANWüstefeldTStrehleMTrautweinCBirchmeierCMet provides essential signals for liver regenerationProc Natl Acad Sci U S A720200410129106081061315249655
   PubMed Web of Science ®Google Scholar
• KosaiKMatsumotoKNagataSTsujimotoYNakamuraTAbrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factorBiochem Biophys Res Commun327199824436836909535725
   PubMed Web of Science ®Google Scholar
• HuhCGFactorVMSánchezAUchidaKConnerEAThorgeirssonSSHepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repairProc Natl Acad Sci U S A3302004101134477448215070743
   PubMed Web of Science ®Google Scholar
• GiebelerABoekschotenMVKleinCc-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in miceGastroenterology720091371297308308.e1419208365
   PubMed Web of Science ®Google Scholar
• MarquardtJUSeoDGómez-QuirozLELoss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathwaysBiochim Biophys Acta620121822694295122386877
   PubMed Web of Science ®Google Scholar
• KroyDCSchumacherFRamadoriPHepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in miceJ Hepatol10201461488389024845607
   PubMed Web of Science ®Google Scholar
• ZouCMaJWangXLack of Fas antagonism by Met in human fatty liver diseaseNat Med920071391078108517704785
   PubMed Web of Science ®Google Scholar
• KimWHMatsumotoKBesshoKNakamuraTGrowth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosisAm J Pathol4200516641017102815793283
   PubMed Web of Science ®Google Scholar
• ZarnegarRMichalopoulosGPurification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytesCancer Res61519894912331433202524251
   PubMed Web of Science ®Google Scholar
• NakamuraTNishizawaTHagiyaMMolecular cloning and expression of human hepatocyte growth factorNature1123198934262484404432531289
   PubMed Web of Science ®Google Scholar
• SuzukiKHayashiNYamadaYExpression of the c-met protooncogene in human hepatocellular carcinomaHepatology111994205123112367927256
   PubMed Web of Science ®Google Scholar
• TavianDDe PetroGBenettiAPortolaniNGiuliniSMBarlatiSu-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinomaInt J Cancer91200087564464910925356
   PubMed Web of Science ®Google Scholar
• UekiTFujimotoJSuzukiTYamamotoHOkamotoEExpression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinomaHepatology419972548628669096589
   PubMed Web of Science ®Google Scholar
• Kaposi-NovakPLeeJSGòmez-QuirozlCoulouarnCFactorVMThorgeirssonSSMet – regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotypeJ Clin Invest6200611661582159516710476
   PubMed Web of Science ®Google Scholar
• D’ErricoAFiorentinoMPonzettoALiver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met doesHepatology7199624160648707284
   PubMed Web of Science ®Google Scholar
• DaveauMScotteMFrançoisAHepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinomaMol Carcinog3200336313014112619035
   PubMed Web of Science ®Google Scholar
• KondoSOjimaHTsudaHClinical impact of c-Met expression and its gene amplification in hepatocellular carcinomaInt J Clin Oncol4201318220721322218908
   PubMed Web of Science ®Google Scholar
• WangZLLiangPDongBWYuXLYu deJPrognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective studyJ Gastrointest Surg2200812232733717943391
   PubMed Web of Science ®Google Scholar
• ShimomuraTKondoJOchiaiMActivation of the zymogen of hepatocyte growth factor activator by thrombinJournal of Biological Chemistry19932683022927229328226803
   PubMed Web of Science ®Google Scholar
• BirchmeierCBirchmeierWGherardiEVande WoudeGFMet, metastasis, motility and moreNature Reviews Molecular Cell Biology200341291592514685170
   PubMed Web of Science ®Google Scholar
• LeeSJLeeJSohnIMaoMKaiWParkCKLimHYA survey of c-MET expression and amplification in 287 patients with hepatocellular carcinomaAnticancer Res11201333115179518624222167
   PubMed Web of Science ®Google Scholar
• TakeoSAraiHKusanoNExamination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysisCancer Genet Cytogenet10151996130212713211675133
   PubMedGoogle Scholar
• WangKLimHYShiSGenomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinomaHepatology8201358270671723505090
   PubMed Web of Science ®Google Scholar
• GuichardCAmaddeoGImbeaudSIntegrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinomaNat Genet56201244669469822561517
   PubMed Web of Science ®Google Scholar
• PennacchiettiSMichieliPGalluzzoMMazzoneMGiordanoSComoglioPMHypoxia promotes invasive growth by transcriptional activation of the met protooncogeneCancer Cell20034343476112726861
   PubMed Web of Science ®Google Scholar
• HarrisALHypoxia-a key regulatory factor in tumor growthNature Rev Cancer2002384811902584
   PubMed Web of Science ®Google Scholar
• YuJLRakJWCoomberBLEffect of p53 status on tumor response to antiangiogenic therapyScience29520021526152811859195
   PubMed Web of Science ®Google Scholar
• SierraJRTsaoMSc-MET as a potential therapeutic target and biomarker in cancerTher Adv Med Oncol11201131 SupplS213522128285
   PubMedGoogle Scholar
• SchmidtLDuhFMChenFGermline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasNat Genet5199716168739140397
   PubMed Web of Science ®Google Scholar
• ParkWSDongSMKimSYSomatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomasCancer Res11519995923073109927037
   PubMed Web of Science ®Google Scholar
• LeeJHHanSUChoHA novel germ line juxtamembrane Met mutation in human gastric cancerOncogene1012200019434947495311042681
   PubMed Web of Science ®Google Scholar
• AebersoldDMLandtOBerthouSPrevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynxOncogene1120200322528519852314627992
   PubMed Web of Science ®Google Scholar
• Wellcome Trust Sanger InstituteCOSMIC-Catalogue of Somatic Mutations in Cancer [webpage on the Internet]Hinxton, Cambridge, UKWellcome Trust Sanger Institute, Genome Research limited2010 Available from: http//www.sanger.ac.uk/genetics/CGP/cosmic/Accessed January 5, 2015
   Google Scholar
• CooperCSParkMBlairDGMolecular cloning of a new transforming gene from a chemically transformed human cell lineNature96–111984311598129336590967
   PubMed Web of Science ®Google Scholar
• LiangTJReidAEXavierRCardiffRDWangTCTransgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumorsJ Clin Invest61519969712287228778675700
   PubMed Web of Science ®Google Scholar
• SomanNRCorreaPRuizBAWoganGNThe TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesionsProc Natl Acad Sci U S A6119918811489248962052572
   PubMed Web of Science ®Google Scholar
• Danilkovitch-MiagkovaAZbarBDysregulation of Met receptor tyrosine kinase activity in invasive tumors.[Review]Clin Invest420021097863867 Review
   Google Scholar
• CorsoSComoglioPMGiordanoSCancer therapy: can the challenge be MET? [Review]Trends Mol Med6200511628429215949770
   PubMed Web of Science ®Google Scholar
• TrusolinoLBertottiAComoglioPMMET signalling: principles and functions in development, organ regeneration and cancer.[Review]Nat Rev Mol Cell Biol122010111283484821102609
   PubMed Web of Science ®Google Scholar
• BoccaccioCGaudinoGGambarottaGGalimiFComoglioPMHepatocyte growthn factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGFJ Biol Chem42919942691712846128518175699
   PubMed Web of Science ®Google Scholar
• WebbCPTaylorGAJeffersMEvidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasisOncogene102219981716201920259798673
   PubMed Web of Science ®Google Scholar
• GambarottaGBoccaccioCGiordanoSAndŏMStellaMCComoglioPMEts up-regulates MET transcriptionOncogene1171996139191119178934537
   PubMed Web of Science ®Google Scholar
• IvanMBondJAPratMComoglioPMWynford-ThomasDActivated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cellsOncogene52219971420241724239188856
   PubMed Web of Science ®Google Scholar
• Orian-RousseauVChenLSleemanJPHerrlichPPontaHCD44 is required for two consecutive steps in HGF/c-Met signalingGenes Dev121200216233074308612464636
   PubMed Web of Science ®Google Scholar
• TrusolinoLBertottiAComoglioPMA signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growthCell11302001107564365411733063
   PubMed Web of Science ®Google Scholar
• BergströmJDWestermarkBHeldinNEEpidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cellsExp Cell Res8252000259129329910942601
   PubMed Web of Science ®Google Scholar
• LuKVChangJPParachoniakCAVEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complexCancer Cell7102012221213522789536
   PubMed Web of Science ®Google Scholar
• KorhanPErdalEKandemişEReciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinomaPLoS One822201498e10527825148256
   PubMed Web of Science ®Google Scholar
• RongSDonehowerLAHansenMFMet proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patientsCancer Res511995559196319707728766
   PubMed Web of Science ®Google Scholar
• MiglioreCPetrelliAGhisoEMicroRNAs impair MET-mediated invasive growthCancer Res121520086824101281013619074879
   PubMed Web of Science ®Google Scholar
• FornariFMilazzoMChiecoPMiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cellsCancer Res615201070125184519320501828
   PubMed Web of Science ®Google Scholar
• HouJLinLZhouWIdentification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinomaCancer Cell215201119223224321316602
   PubMed Web of Science ®Google Scholar
• KorhanPErdalEAtabeyNMiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-MetBiochem Biophys Res Commun88201445041304131225058462
   PubMed Web of Science ®Google Scholar
• YangXZhangXFLuXMicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathwayHepatology520145951874188524259426
   PubMed Web of Science ®Google Scholar
• TakedaSLiuHSasagawaSHGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinomaJ Clin Invest71201312373154316523934123
   PubMed Web of Science ®Google Scholar
• OzakiIMizutaTZhaoGInduction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1Hepatol Res12200327428930114662117
   PubMed Web of Science ®Google Scholar
• ComoglioPMTrusolinoLInvasive growth: from development to metastasis. [Review]J Clin Invest42002109785786211927611
   PubMed Web of Science ®Google Scholar
• TrusolinoLComoglioPMScatter-factor and semaphorin receptors: cell signalling for invasive growth. [Review]Nat Rev Cancer420022428930012001990
   PubMed Web of Science ®Google Scholar
• MichalopoulosGKDeFrancesMCLiver regeneration.[Review]Science441997276530960669082986
   PubMed Web of Science ®Google Scholar
• RabkinRFervenzaFTsaoTHepatocyte growth factor receptor in acute tubular necrosisJ Am Soc Nephrol3200112353154011181801
   PubMed Web of Science ®Google Scholar
• BoccaccioCComoglioPMInvasive growth: a MET-driven genetic programme for cancer and stem cells. [Review]Nat Rev Cancer820066863764516862193
   PubMed Web of Science ®Google Scholar
• WangRFerrellLDFaouziSMaherJJBishopJMActivation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic miceJ Cell Biol528200115351023103411381087
   PubMed Web of Science ®Google Scholar
• SakataHTakayamaHSharpRRubinJSMerlinoGLaRochelleWJHepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse liversCell Growth Differ111996711151315238930401
   PubMedGoogle Scholar
• AmiconeLTerradillosOCalvoLSynergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformationOncogene22120022191335134511857077
   PubMed Web of Science ®Google Scholar
• ZhangSZPanFYXuJFKnockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivoMol Cancer Ther1020054101577158416227408
   PubMed Web of Science ®Google Scholar
• XieBXingRChenPDown-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interferenceJ Surg Res82010162223123819765730
   PubMed Web of Science ®Google Scholar
• TakamiTKaposi-NovakPUchidaKLoss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesisCancer Res1015200767209844985117942915
   PubMed Web of Science ®Google Scholar
• LiuMLMarsWMMichalopoulosGKHepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamineCarcinogenesis419951648418437728965
   PubMed Web of Science ®Google Scholar
• Marx-StoeltingPBorowiakMKnorppTBirchmeierCBuchmannASchwarzMHepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-MetInt J Cancer415200912481767767219123478
   PubMed Web of Science ®Google Scholar
• KimWHMatsumotoKBesshoKNakamuraTGrowth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosisAm J Pathol4200516641017102815793283
   PubMed Web of Science ®Google Scholar
• ConnerEATeramotoTWirthPJKissAGarfieldSThorgeirssonSSHGF-mediated apoptosis via p53/bax-independent pathway activating JNK1Carcinogenesis4199920458359010223185
   PubMed Web of Science ®Google Scholar
• SmythECSclafaniFCunninghamDEmerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors.[Review]Onco Targets Ther612201471001101424959087
   PubMed Web of Science ®Google Scholar
• SantoroASimonelliMRodriguez-LopeCA Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosisBr J Cancer11520131081212423287988
   PubMed Web of Science ®Google Scholar
• SantoroARimassaLBorbathITivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 studyLancet Oncol12013141556323182627
   PubMed Web of Science ®Google Scholar
• GoyalLMuzumdarMDZhuAXTargeting the HGF/c-MET pathway in hepatocellular carcinoma.[Review]Clin Cancer Res5120131992310231823388504
   PubMed Web of Science ®Google Scholar
• XiangQChenWRenMWangJZhangHDengDYZhangLShangCChenYCabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and METClin Cancer Res61201420112959295724700742
   PubMed Web of Science ®Google Scholar
• VerslypeCCohnALKelleyRKActivity of cabozantinib (XL184) in hepatocellular carcinoma: Results from a phase II randomized discontinuation trial (RDT)American Society of clinical oncology 2012 Annual MeetingJune 1–5, 2012Chicago, ILJ Clin Oncol201230suppl Abstract #4007
   Google Scholar
• KnudsenBSVande WoudeGShowering c-MET-dependent cancers with drugsCurr Opin Genet Dev22008181879618406132
   PubMed Web of Science ®Google Scholar